Guangdong VTR Bio-Tech Co (300381) Fair Value & Analysis
Healthcare · CN · Market cap 2.8B CNY
Fair value as of: Jun 24, 2026
Analysis
Guangdong VTR Bio-Tech Co (300381) currently trades at ¥5.97, while our model-based Fair Value estimate is ¥1.96 — implying the stock looks roughly 67.2% overvalued today. We read business quality at 93/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services bio-enzyme preparations, biosynthetics, and nutrition and health products in China and internationally. The company offers animal nutrition and health, biofuel, detergent, food and beverage, brewing, starch sweetness, bakery, plant extracts, pulp and paper, and textile enzymes, as well as biotechnology solutions. It also provides active natural products. The company also exports its products. The company was founded in 1991 and is based in Zhuhai, China.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Guangdong VTR Bio-Tech Co (300381) undervalued?
What is the fair value of 300381?
What is the quality score of 300381?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.